UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor‐derived extracellular vesicles

Journal of thrombosis and haemostasis, 2018-09, Vol.16 (9), p.1800-1813

2018

Link zum Volltext

Verfügbarkeit prüfen

An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer

Oncogene, 2012-04, Vol.31 (16), p.2090-2100

2012

Link zum Volltext

Verfügbarkeit prüfen

Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes

Oncogene, 2011-03, Vol.30 (11), p.1318-1328

2011

Link zum Volltext

Verfügbarkeit prüfen

How iMALDI can improve clinical diagnostics

Analyst (London), 2018-05, Vol.143 (1), p.2197-223

2018

Link zum Volltext

Verfügbarkeit prüfen

Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer

ESMO open, 2023-08, Vol.8 (4), p.101615-101615, Article 101615

2023

Link zum Volltext

Verfügbarkeit prüfen

Gender differences in how physicians access and process information

Gynecologic oncology reports, 2019-02, Vol.27, p.50-53

2019

Link zum Volltext

Verfügbarkeit prüfen

MC13-0077 Array CGH analysis of paired metastatic biopsies obtained pre-treatment and at resistance to FOLFOX-bevacizumab in metastatic CRC patients

European journal of cancer (1990), 2013-11, Vol.49, p.S33-S33

2013

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

The New England journal of medicine, 2019-02, Vol.380 (7), p.617-628

2019

Link zum Volltext

Verfügbarkeit prüfen

Development of a multiplexed protein panel using a targeted proteomics approach for the study of CDK4/6 inhibitors resistance in hormone receptor positive breast cancer

European journal of cancer (1990), 2020-10, Vol.138, p.S120-S120

2020

Link zum Volltext

Verfügbarkeit prüfen

137P Combining protein and mRNA spatial profiles to identify distinct cell population in metaplastic breast cancer

Annals of oncology, 2022-10, Vol.33, p.S1426-S1426

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-08-08: Age-Related differences in clinicopathologic features and survival amongst women with triple negative breast cancer: A population-based study

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P6-P6-08-08

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-09-19: Tumor RNA disruption index as a tool to predict response to neoadjuvant chemotherapy in breast cancer: Optimizing timing of biopsy

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-09-19

2017

Link zum Volltext

Verfügbarkeit prüfen

P19 A novel way of assessing health and vulnerability in older newly-diagnosed cancer patients: results of a pilot study

Critical reviews in oncology/hematology, 2009, Vol.72 (1), p.S25-S26

2009

Link zum Volltext

Verfügbarkeit prüfen

99P Exploratory analysis of differential gene expression (DGE) and non-negative matrix factorisation (NMF) clustering in KATHERINE: Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (H) in patients with HER2-positive residual invasive breast cancer after neoadjuvant treatment (NAT)

ESMO open, 2023-05, Vol.8 (1), p.101323, Article 101323

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-02-02: Dynamics of ctDNA changes during neoadjuvant chemotherapy in triple-negative breast cancer patients

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-02-02

2018

Link zum Volltext

Verfügbarkeit prüfen

RNAi microarray analysis in cultured mammalian cells

Genome research, 2003-10, Vol.13 (10), p.2341

2003

Link zum Volltext

Verfügbarkeit prüfen

Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer

Nature genetics, 2004-09, Vol.36 (9), p.979-983

2004

Link zum Volltext

Verfügbarkeit prüfen

P.31 A novel way of assessing health and vulnerability in older newly diagnosed cancer patients: preliminary results of an ongoing prospective pilot study

Critical reviews in oncology/hematology, 2007-11, Vol.64, p.S45-S46

2007

Link zum Volltext

Verfügbarkeit prüfen

Abstract OT1-09-01: Phase II trial assessing accuracy of tumor bed biopsies in predicting pathologic response in patients with clinical/radiological complete response after neoadjuvant chemotherapy in order to explore the feasibility of breast-conserving surgery without surgery: NRG Oncology BR005

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT1-09-01-OT1-09-01

2019

Link zum Volltext

Verfügbarkeit prüfen

The Onset and Extent of Genomic Instability in Sporadic Colorectal Tumor Progression

Proceedings of the National Academy of Sciences - PNAS, 1999-12, Vol.96 (26), p.15121-15126

1999

Link zum Volltext

Verfügbarkeit prüfen

p53 Tumor Suppressor Gene Status and the Degree of Genomic Instability in Sporadic Colorectal Cancers

JNCI : Journal of the National Cancer Institute, 1996-11, Vol.88 (22), p.1665-1670

1996

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-03-03: The Q-CROC-3 project reveals novel genomic alterations in triple negative breast cancers in residual tumors after neoadjuvant chemotherapy

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P6-P6-03-03

2016

Link zum Volltext

Verfügbarkeit prüfen

Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-α and IFN-γ

Journal of leukocyte biology, 2004-07, Vol.76 (1), p.217-226

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(101)

Sprache

Englisch
(101)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor‐derived extracellular vesicles

An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer

Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes

How iMALDI can improve clinical diagnostics

Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer

Gender differences in how physicians access and process information

MC13-0077 Array CGH analysis of paired metastatic biopsies obtained pre-treatment and at resistance to FOLFOX-bevacizumab in metastatic CRC patients

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Development of a multiplexed protein panel using a targeted proteomics approach for the study of CDK4/6 inhibitors resistance in hormone receptor positive breast cancer

137P Combining protein and mRNA spatial profiles to identify distinct cell population in metaplastic breast cancer

Abstract P6-08-08: Age-Related differences in clinicopathologic features and survival amongst women with triple negative breast cancer: A population-based study

Abstract P1-09-19: Tumor RNA disruption index as a tool to predict response to neoadjuvant chemotherapy in breast cancer: Optimizing timing of biopsy

The MNK1/2-eIF4E Axis Supports Immune Suppression and Metastasis in Postpartum Breast Cancer

P19 A novel way of assessing health and vulnerability in older newly-diagnosed cancer patients: results of a pilot study

An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis

99P Exploratory analysis of differential gene expression (DGE) and non-negative matrix factorisation (NMF) clustering in KATHERINE: Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (H) in patients with HER2-positive residual invasive breast cancer after neoadjuvant treatment (NAT)

Abstract P2-02-02: Dynamics of ctDNA changes during neoadjuvant chemotherapy in triple-negative breast cancer patients

RNAi microarray analysis in cultured mammalian cells

Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer

P.31 A novel way of assessing health and vulnerability in older newly diagnosed cancer patients: preliminary results of an ongoing prospective pilot study

Abstract OT1-09-01: Phase II trial assessing accuracy of tumor bed biopsies in predicting pathologic response in patients with clinical/radiological complete response after neoadjuvant chemotherapy in order to explore the feasibility of breast-conserving surgery without surgery: NRG Oncology BR005

The Onset and Extent of Genomic Instability in Sporadic Colorectal Tumor Progression

p53 Tumor Suppressor Gene Status and the Degree of Genomic Instability in Sporadic Colorectal Cancers

Abstract P6-03-03: The Q-CROC-3 project reveals novel genomic alterations in triple negative breast cancers in residual tumors after neoadjuvant chemotherapy

Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-α and IFN-γ

Suchergebnisse filtern